⌘K

Login Start Free

Home/Filings/4/0001127602-25-016419

4//SEC Filing

Frank Steven 4

Accession 0001127602-25-016419

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:05 PM ET

Size

4.5 KB

Accession

0001127602-25-016419

Insider Transaction Report

Form 4

Period: 2025-05-30

BIOCRYST PHARMACEUTICALS INCBCRX

Director

Transactions

Award
Common Stock
2025-05-30$10.75/sh+333$3,580→ 2,199 total

Footnotes (1)

[F1]Shares of Common Stock issued to the reporting person in lieu of 100% of the prorated quarterly cash Board Member retainer of $3,585.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001583886

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 4:05 PM ET
Size: 4.5 KB

View on SEC.gov